Redacted Settlement Offers Are Admissible to Show Industry Practice for FRAND Negotiations

May 9, 2024

Reading Time : 2 min

In advance of a new trial to determine damages for patent infringement, a district court denied plaintiff’s motion to preclude defendants from introducing the terms of plaintiff’s settlement offers. The district court concluded that the licensing offers had probative value to show industry practice for negotiating licenses on fair, reasonable, and non-discriminatory (FRAND) terms.

Following a jury verdict of partial infringement, the court sua sponte ordered a new trial on damages in light of its concerns that the jury was confused about different forms of reasonable royalty damages. Plaintiff filed a motion requesting that the court prohibit defendants from introducing the terms of plaintiff’s settlement offers during the new trial. The settlement offers were introduced in the original trial for the purpose of determining whether plaintiff breached its commitment to negotiate a license under FRAND terms. In the new trial, plaintiff contended that because the settlement offers could not be used to determine the amount of damages, the offers should not be admitted.

Defendants sought to admit the settlement offers to establish the industry practice for FRAND license negotiations. Specifically, defendants sought to introduce the offers as evidence of the parties’ valuation of the asserted patents relative to plaintiff’s broader portfolio. Defendants also argued that the valuation methodology contained in the offers is evidence of industry practice.  According to defendants, the offers showed a lump sum structure for licensing the patents. Defendants stated that they were willing to prepare redacted versions of the offers to remove numerical amounts, while preserving discussion of valuation, methodology, and license payments. 

The court denied plaintiff’s motion and ordered that the settlement offers be redacted as outlined by defendants. The court agreed with defendants that the offers had probative value for determining damages in the new trial. The court concluded that the offers could be used to show industry practice for FRAND licensing negotiations, including the specific practices of the parties. Further, the court stated that introducing the offers, once redacted, would not run afoul of Federal Rule of Evidence 408, which safeguards against the use of compromise negotiations to prove or disprove the validity or amount of a disputed claim. 

Practice Tip: While settlement or licensing negotiations can serve as evidence of FRAND terms for patent damages, Federal Rule of Evidence 408 dictates that such negotiations cannot be used to prove or disprove the validity or amount of the infringement claim. Parties seeking to introduce evidence related to settlement in FRAND negotiations should consider whether introduction of such evidence in toto is necessary or desirable. For example, appropriate redactions can prevent consideration of compromise negotiations for an improper purpose while allowing the negotiations to serve as evidence of FRAND terms and industry practice.    

G+ Commc’ns, LLC v. Samsung Elecs. Co., 2:22-cv-00078-JRG, D.I. 625 (E.D. Tex. Apr. 12, 2024). 

Share This Insight

Categories

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.